Tilray | Betriebsaufwand


Operating Expenses Veränderung Datum
Acasti Pharma USD 3.09M 49.05M 2025-06
Alaunos Therapeutics USD 759K 391K 2024-12
Aurora Cannabis CAD 118.24M 66.26M 2025-06
Avita Medical AUD 28.36M 2.44M 2024-12
Canopy Growth CAD 94.22M 4.36M 2025-06
Cronos Group USD 37.84M 1.5M 2025-06
Dianthus Therapeutics USD 35.12M 1.88M 2025-06
Divis Laboratories Ltd 17.93B 130M 2025-06
Ionis Pharmaceuticals USD 312.21M 34.21M 2025-06
IQVIA Holdings USD 3.46B 124M 2025-06
Knight Therapeutics CAD 89.06M 2.02M 2024-09
Moderna USD 1.04B 113M 2025-06
Organigram Holdings CAD 72.9M 18.86M 2025-06
Organon & Co USD 1.27B 144M 2025-06
Revvity USD 629.52M 36.99M 2025-06
Tectonic Therapeutic USD 22.33M 8.34M 2025-06
Tilray USD 253.17M 16.55M 2024-11
Viatris USD 3.4B 2.88B 2025-06
Xeris Pharmaceuticals USD 67.06M 8.64M 2025-06


Tilray Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2025.